Industry

ZoyMed

A medical technology company in China contributing to academic research on artificial intelligence for cancer diagnostics and digital pathology.

Location: China
1 model

Models (1)

SmartStu

South China University of Technology / University of Leicester / University of Oxford / Hong Kong University of Science and Technology / ZoyMed

Released August 2, 2026

1

Breast cancer histopathology foundation model distilled from three general-purpose PFMs, over 30x smaller with comparable balanced accuracy and AUC.

Pathology